Elicio Therapeutics(ELTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ELTX Elicio Therapeutics

休市中 12-20 15:59:59 EST

4.88

-0.23

-4.50%

盘后4.88

+0.000.00%

16:00 EST

最高5.02	最低4.70	成交量2.53万
今开5.00	昨收5.11	日振幅6.26%
总市值5,259万	流通市值4,098万	总股本1,078万
成交额12.32万	换手率0.30%	流通股本839.73万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ELTX","market":"US","secType":"STK","nameCN":"Elicio Therapeutics","latestPrice":4.88,"timestamp":1734728399999,"preClose":5.11,"halted":0,"volume":25347,"hourTrading":{"tag":"盘后","latestPrice":4.88,"preClose":4.88,"latestTime":"16:00 EST","volume":99,"amount":483.12,"timestamp":1734728404541},"delay":0,"floatShares":8397273,"shares":10776871,"eps":-4.28727,"marketStatus":"休市中","marketStatusCode":7,"change":-0.23,"latestTime":"12-20 15:59:59 EST","open":5,"high":5.02,"low":4.7,"amount":123155.800824,"amplitude":0.062622,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.28727,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1612501200000,"adjPreClose":5.11,"postHourTrading":{"tag":"盘后","latestPrice":4.88,"preClose":4.88,"latestTime":"16:00 EST","volume":99,"amount":483.12,"timestamp":1734728404541},"volumeRatio":1.0101706489323696},"requestUrl":"/m/hq/s/ELTX","defaultTab":"news","newsList":[{"id":"2493424202","title":"Elicio Therapeutics, Inc.盘中异动 急速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493424202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493424202?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:49","pubTimestamp":1734716956,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时49分，Elicio Therapeutics, Inc.股票出现异动，股价大幅跳水5.81%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101491695ea9f4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101491695ea9f4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2492077961","title":"Elicio Therapeutics, Inc.股价上涨11.00% 市值跌156.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492077961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492077961?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:43","pubTimestamp":1734450194,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时43分，Elicio Therapeutics, Inc.股票出现异动，股价大幅上涨11.00%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121723431495ea33b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121723431495ea33b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ELTX","BK4007"],"gpt_icon":0},{"id":"2490826663","title":"Elicio Therapeutics, Inc.盘中异动 早盘股价大涨5.08%报5.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490826663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490826663?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:32","pubTimestamp":1734013934,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时32分，Elicio Therapeutics, Inc.股票出现异动，股价大幅上涨5.08%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223215a1e950d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223215a1e950d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2490414520","title":"Elicio Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490414520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490414520?lang=zh_cn&edition=full","pubTime":"2024-12-11 01:55","pubTimestamp":1733853346,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日01时55分，Elicio Therapeutics, Inc.股票出现波动，股价快速下跌5.01%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211015547ab6d4eac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211015547ab6d4eac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ELTX"],"gpt_icon":0},{"id":"2490779253","title":"Elicio Therapeutics, Inc.盘中异动 早盘股价大涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490779253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490779253?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:27","pubTimestamp":1733758030,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时27分，Elicio Therapeutics, Inc.股票出现异动，股价急速拉升5.75%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209232710a1e0c651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209232710a1e0c651&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ELTX"],"gpt_icon":0},{"id":"2489499832","title":"Elicio Therapeutics, Inc.盘中异动 下午盘大幅跳水5.14%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489499832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489499832?lang=zh_cn&edition=full","pubTime":"2024-12-06 02:45","pubTimestamp":1733424302,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日02时45分，Elicio Therapeutics, Inc.股票出现异动，股价急速下挫5.14%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206024502a1d70dc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206024502a1d70dc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2488950921","title":"Elicio Therapeutics, Inc.盘中异动 急速下跌5.00%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488950921","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488950921?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:16","pubTimestamp":1733249783,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日02时16分，Elicio Therapeutics, Inc.股票出现异动，股价大幅下跌5.00%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204021623abf35d67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204021623abf35d67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2485981152","title":"Elicio Therapeutics, Inc.2024财年第三财季实现净利润-18.84百万美元，同比减少76.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485981152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485981152?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291277,"startTime":"0","endTime":"0","summary":"11月23日，Elicio Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-18.84百万美元，同比减少76.74%；其中营业收入为0.00美元，每股基本收益为-1.39美元。机构评级：截至2024年11月23日，当前有2家机构对Elicio Therapeutics, Inc.目标价做出预测，其中目标均价为9.50美元，其中最低目标价为9.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000141abd7b874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000141abd7b874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ"],"gpt_icon":0},{"id":"2485446177","title":"Elicio Therapeutics, Inc.盘中异动 下午盘股价大涨6.59%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446177?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:32","pubTimestamp":1732213959,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时32分，Elicio Therapeutics, Inc.股票出现波动，股价急速拉升6.59%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122023239abd54acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122023239abd54acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ELTX"],"gpt_icon":0},{"id":"2485149987","title":"Elicio Therapeutics, Inc.盘中异动 早盘急速下挫5.49%报4.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485149987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485149987?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:00","pubTimestamp":1732118454,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时00分，Elicio Therapeutics, Inc.股票出现波动，股价急速跳水5.49%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000055abd25be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000055abd25be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ELTX"],"gpt_icon":0},{"id":"2484860963","title":"Elicio Therapeutics, Inc.盘中异动 快速下挫10.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484860963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484860963?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:41","pubTimestamp":1731951692,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时41分，Elicio Therapeutics, Inc.股票出现异动，股价快速下挫10.04%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901413298e43519&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901413298e43519&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2483372804","title":"Elicio Therapeutics, Inc.盘中异动 快速上涨7.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:36","pubTimestamp":1731594972,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时36分，Elicio Therapeutics, Inc.股票出现异动，股价快速上涨7.86%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223612971a68f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223612971a68f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2482438579","title":"Elicio Therapeutics, Inc.盘中异动 急速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482438579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482438579?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:40","pubTimestamp":1731087651,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时40分，Elicio Therapeutics, Inc.股票出现异动，股价急速上涨5.21%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109014052a2252ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109014052a2252ef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2481604046","title":"Elicio Therapeutics Inc  预计每股亏损 73 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481604046","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481604046?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:56","pubTimestamp":1730901396,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics Inc  预计每股亏损 73 美分 - 财报前瞻Elicio Therapeutics Inc ELTX.OQ ELTX.O预计在11月7日公布截至0001年1月1日的业绩时，季度收入将没有变化(预计)。LSEG 的分析师平均预计 Elicio Therapeutics Inc 每股亏损 73 美分。华尔街对 Elicio Therapeutics Inc 的 12 个月目标价中位数为 9.50 美元，高于其最新收盘价 4.84 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD281:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX"],"gpt_icon":0},{"id":"2481682684","title":"Elicio Therapeutics, Inc.盘中异动 早盘快速上涨5.21%报4.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481682684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481682684?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:59","pubTimestamp":1730822343,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日23时59分，Elicio Therapeutics, Inc.股票出现波动，股价急速拉升5.21%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110523590498e4096a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110523590498e4096a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ELTX"],"gpt_icon":0},{"id":"2480584758","title":"Elicio Therapeutics, Inc.盘中异动 早盘股价大跌7.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584758?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:53","pubTimestamp":1730732003,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时53分，Elicio Therapeutics, Inc.股票出现异动，股价大幅下跌7.88%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225324971a42cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225324971a42cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ELTX"],"gpt_icon":0},{"id":"2480832110","title":"Elicio Therapeutics, Inc.盘中异动 股价大涨7.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480832110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480832110?lang=zh_cn&edition=full","pubTime":"2024-11-02 00:45","pubTimestamp":1730479532,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日00时45分，Elicio Therapeutics, Inc.股票出现异动，股价大幅上涨7.75%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110200453298e400f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110200453298e400f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2479164033","title":"Elicio Therapeutics, Inc.盘中异动 大幅拉升5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479164033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479164033?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:47","pubTimestamp":1730382478,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时47分，Elicio Therapeutics, Inc.股票出现波动，股价快速拉升5.77%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.39%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121475898e3fb83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121475898e3fb83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ELTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2479236206","title":"Elicio Therapeutics, Inc.盘中异动 急速下挫7.48%报4.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479236206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479236206?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:29","pubTimestamp":1730219396,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时29分，Elicio Therapeutics, Inc.股票出现异动，股价急速下挫7.48%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000295698e3f276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000295698e3f276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ELTX"],"gpt_icon":0},{"id":"2478480169","title":"Elicio Therapeutics, Inc.盘中异动 股价大跌5.27%报4.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478480169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478480169?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:03","pubTimestamp":1730127839,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时03分，Elicio Therapeutics, Inc.股票出现异动，股价大幅下挫5.27%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823040098e3eddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823040098e3eddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","BK4007","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://elicio.com","stockEarnings":[{"period":"1week","weight":-0.0375},{"period":"1month","weight":-0.0259},{"period":"3month","weight":-0.0375},{"period":"6month","weight":-0.2695},{"period":"1year","weight":-0.1586},{"period":"ytd","weight":-0.4149}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Elicio Therapeutics Inc于1998年4月6日在特拉华州成立。该公司是一家临床阶段的生物技术公司，正在开发一系列新型免疫疗法，用于治疗癌症和其他疾病。通过结合免疫学和免疫疗法方面的专业知识，Elicio正在设计研究性两亲（AMP）免疫疗法，旨在精确地靶向和完全接合淋巴结。Elicio是工程淋巴结靶向为一系列侵袭性癌症和传染病生产AMPlifiers，免疫调节剂，佐剂，和疫苗。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.218043},{"month":2,"riseRate":0,"avgChangeRate":-0.16654},{"month":3,"riseRate":0.75,"avgChangeRate":0.240014},{"month":4,"riseRate":0.5,"avgChangeRate":-0.026973},{"month":5,"riseRate":0.75,"avgChangeRate":0.162305},{"month":6,"riseRate":0,"avgChangeRate":-0.254842},{"month":7,"riseRate":0.5,"avgChangeRate":0.007352},{"month":8,"riseRate":0.25,"avgChangeRate":-0.105324},{"month":9,"riseRate":0.5,"avgChangeRate":0.034006},{"month":10,"riseRate":0.25,"avgChangeRate":-0.21101},{"month":11,"riseRate":0.25,"avgChangeRate":-0.044694},{"month":12,"riseRate":0.25,"avgChangeRate":0.019396}],"exchange":"NASDAQ","name":"Elicio Therapeutics","nameEN":"Elicio Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Elicio Therapeutics(ELTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Elicio Therapeutics(ELTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Elicio Therapeutics,ELTX,Elicio Therapeutics股票,Elicio Therapeutics股票老虎,Elicio Therapeutics股票老虎国际,Elicio Therapeutics行情,Elicio Therapeutics股票行情,Elicio Therapeutics股价,Elicio Therapeutics股市,Elicio Therapeutics股票价格,Elicio Therapeutics股票交易,Elicio Therapeutics股票购买,Elicio Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Elicio Therapeutics(ELTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Elicio Therapeutics(ELTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}